AJANTPHARM.BOAJANTPHARM.BOBSE
Loading
Year-over-year net income growth rate
5Y CAGR
+6.7%/yr
Long-term compound
Percentile
P49
Within normal range
vs 5Y Ago
1.4x
Solid growth
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 5.22% |
| Q3 2025 | 1.90% |
| Q2 2025 | 13.35% |
| Q1 2025 | -3.27% |
| Q4 2024 | 7.58% |
| Q3 2024 | -11.92% |
| Q2 2024 | 21.24% |
| Q1 2024 | -3.48% |
| Q4 2023 | 7.54% |
| Q3 2023 | -6.16% |
| Q2 2023 | 70.24% |
| Q1 2023 | -9.11% |
| Q4 2022 | -14.11% |
| Q3 2022 | -10.32% |
| Q2 2022 | 15.48% |
| Q1 2022 | -21.15% |
| Q4 2021 | -2.12% |
| Q3 2021 | 12.77% |
| Q2 2021 | 9.10% |
| Q1 2021 | -9.83% |
| Q4 2020 | 3.77% |
| Q3 2020 | 15.20% |
| Q2 2020 | 14.40% |
| Q1 2020 | 20.09% |
| Q4 2019 | -7.57% |
| Q3 2019 | 1.51% |
| Q2 2019 | 28.96% |
| Q1 2019 | 32.87% |
| Q4 2018 | -46.65% |
| Q3 2018 | 18.53% |
| Q2 2018 | 11.96% |
| Q1 2018 | -35.93% |
| Q4 2017 | 11.81% |
| Q3 2017 | 39.14% |
| Q2 2017 | -16.87% |
| Q1 2017 | -20.04% |
| Q4 2016 | 9.14% |
| Q3 2016 | 9.29% |
| Q2 2016 | 9.72% |
| Q1 2016 | -2.10% |